 David Partrick
Concepts (500)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 19 | 2022 | 274 | 2.400 |
Why?
| | Thoracoscopy | 9 | 2019 | 56 | 1.880 |
Why?
| | Appendicitis | 6 | 2018 | 130 | 1.400 |
Why?
| | Myasthenia Gravis | 2 | 2020 | 23 | 1.300 |
Why?
| | Laparoscopy | 13 | 2015 | 464 | 1.280 |
Why?
| | Spleen | 5 | 2019 | 516 | 1.280 |
Why?
| | Multiple Organ Failure | 14 | 2010 | 127 | 1.250 |
Why?
| | Trauma Centers | 19 | 2022 | 419 | 1.080 |
Why?
| | Funnel Chest | 3 | 2021 | 27 | 1.040 |
Why?
| | Appendectomy | 6 | 2018 | 79 | 1.010 |
Why?
| | Child | 72 | 2022 | 21896 | 0.910 |
Why?
| | Fundoplication | 7 | 2016 | 54 | 0.890 |
Why?
| | Brain Injuries | 6 | 2015 | 489 | 0.880 |
Why?
| | Postoperative Care | 2 | 2016 | 258 | 0.850 |
Why?
| | Blood Transfusion | 4 | 2022 | 324 | 0.830 |
Why?
| | Injury Severity Score | 19 | 2022 | 522 | 0.830 |
Why?
| | Child, Preschool | 52 | 2021 | 11013 | 0.810 |
Why?
| | Length of Stay | 15 | 2019 | 1203 | 0.810 |
Why?
| | Retrospective Studies | 53 | 2024 | 15514 | 0.780 |
Why?
| | Forecasting | 3 | 2019 | 386 | 0.730 |
Why?
| | Analgesia, Epidural | 1 | 2021 | 33 | 0.720 |
Why?
| | Gastroesophageal Reflux | 5 | 2016 | 235 | 0.720 |
Why?
| | Wounds and Injuries | 11 | 2016 | 743 | 0.710 |
Why?
| | Empyema | 1 | 2021 | 5 | 0.710 |
Why?
| | Nerve Block | 1 | 2021 | 76 | 0.690 |
Why?
| | Gastrostomy | 6 | 2024 | 113 | 0.690 |
Why?
| | Mediastinal Neoplasms | 3 | 2014 | 45 | 0.680 |
Why?
| | Thymectomy | 1 | 2019 | 15 | 0.660 |
Why?
| | Colonic Pouches | 1 | 2019 | 15 | 0.650 |
Why?
| | Neutrophils | 15 | 2002 | 1237 | 0.630 |
Why?
| | Phlebotomy | 1 | 2019 | 21 | 0.620 |
Why?
| | Colectomy | 1 | 2019 | 99 | 0.620 |
Why?
| | Adolescent | 56 | 2022 | 21402 | 0.610 |
Why?
| | Chest Tubes | 2 | 2019 | 29 | 0.600 |
Why?
| | Child Abuse | 6 | 2014 | 542 | 0.590 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 130 | 0.580 |
Why?
| | Infant | 35 | 2024 | 9408 | 0.560 |
Why?
| | Liver | 4 | 2019 | 1937 | 0.560 |
Why?
| | Leukocyte Elastase | 8 | 2002 | 77 | 0.560 |
Why?
| | Intubation, Gastrointestinal | 5 | 2024 | 77 | 0.550 |
Why?
| | Delayed Diagnosis | 2 | 2015 | 91 | 0.550 |
Why?
| | Biopsy | 3 | 2016 | 1130 | 0.550 |
Why?
| | Humans | 119 | 2024 | 136899 | 0.540 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2015 | 10 | 0.530 |
Why?
| | Male | 72 | 2021 | 67308 | 0.520 |
Why?
| | Platelet Activating Factor | 6 | 2000 | 76 | 0.510 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1057 | 0.510 |
Why?
| | Female | 73 | 2019 | 72703 | 0.490 |
Why?
| | Digestive System Surgical Procedures | 3 | 2014 | 106 | 0.480 |
Why?
| | Pulmonary Surgical Procedures | 1 | 2015 | 8 | 0.480 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 43 | 0.480 |
Why?
| | Minimally Invasive Surgical Procedures | 5 | 2014 | 181 | 0.480 |
Why?
| | Surgery Department, Hospital | 1 | 2015 | 20 | 0.470 |
Why?
| | Abdominal Abscess | 2 | 2012 | 27 | 0.470 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2015 | 20 | 0.470 |
Why?
| | Ileal Diseases | 1 | 2014 | 13 | 0.460 |
Why?
| | Angiography | 2 | 2015 | 208 | 0.460 |
Why?
| | Superoxides | 12 | 2002 | 202 | 0.450 |
Why?
| | Accidents | 1 | 2014 | 39 | 0.450 |
Why?
| | Postoperative Complications | 10 | 2022 | 2627 | 0.430 |
Why?
| | Embolization, Therapeutic | 2 | 2015 | 227 | 0.420 |
Why?
| | Hemoglobins | 5 | 2022 | 356 | 0.410 |
Why?
| | Device Removal | 1 | 2014 | 138 | 0.410 |
Why?
| | Registries | 8 | 2014 | 2006 | 0.390 |
Why?
| | Phospholipases A | 4 | 2001 | 102 | 0.390 |
Why?
| | Electroencephalography | 1 | 2015 | 436 | 0.380 |
Why?
| | Tomography, X-Ray Computed | 8 | 2021 | 2670 | 0.380 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 248 | 0.380 |
Why?
| | Pancreatic Elastase | 6 | 2001 | 60 | 0.370 |
Why?
| | Abdominal Injuries | 4 | 2015 | 123 | 0.370 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 339 | 0.370 |
Why?
| | Neutrophil Activation | 4 | 2000 | 81 | 0.370 |
Why?
| | Anesthesia | 1 | 2014 | 190 | 0.370 |
Why?
| | Crohn Disease | 1 | 2014 | 237 | 0.350 |
Why?
| | Multiple Trauma | 8 | 2005 | 101 | 0.350 |
Why?
| | Colorado | 20 | 2018 | 4491 | 0.340 |
Why?
| | Disease Management | 1 | 2014 | 624 | 0.340 |
Why?
| | Intercellular Adhesion Molecule-1 | 4 | 2001 | 139 | 0.330 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2010 | 65 | 0.330 |
Why?
| | Wounds, Gunshot | 1 | 2013 | 218 | 0.320 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 193 | 0.320 |
Why?
| | Suture Techniques | 1 | 2010 | 122 | 0.320 |
Why?
| | Neoplasms | 2 | 2015 | 2655 | 0.320 |
Why?
| | Shock, Hemorrhagic | 3 | 2016 | 168 | 0.320 |
Why?
| | Treatment Outcome | 19 | 2016 | 10768 | 0.310 |
Why?
| | Hypotension | 2 | 2016 | 123 | 0.300 |
Why?
| | Craniocerebral Trauma | 4 | 2014 | 168 | 0.290 |
Why?
| | Head Injuries, Closed | 2 | 2011 | 48 | 0.290 |
Why?
| | Leukotriene B4 | 2 | 1998 | 42 | 0.290 |
Why?
| | Thoracic Surgical Procedures | 2 | 2005 | 73 | 0.280 |
Why?
| | Laparotomy | 5 | 2015 | 109 | 0.280 |
Why?
| | Enteral Nutrition | 4 | 2015 | 196 | 0.270 |
Why?
| | Lung | 4 | 2015 | 4046 | 0.270 |
Why?
| | Hemorrhage | 2 | 2016 | 718 | 0.270 |
Why?
| | Risk Factors | 16 | 2015 | 10313 | 0.260 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1790 | 0.250 |
Why?
| | Endoscopy | 2 | 2007 | 315 | 0.250 |
Why?
| | Glasgow Coma Scale | 3 | 2015 | 182 | 0.250 |
Why?
| | Sternum | 1 | 2005 | 25 | 0.250 |
Why?
| | Pain, Postoperative | 2 | 2021 | 271 | 0.240 |
Why?
| | Mediastinum | 1 | 2005 | 25 | 0.240 |
Why?
| | Infant, Newborn | 14 | 2016 | 6043 | 0.240 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2833 | 0.230 |
Why?
| | Intraoperative Period | 2 | 2015 | 59 | 0.230 |
Why?
| | Hematocrit | 2 | 2015 | 95 | 0.230 |
Why?
| | Follow-Up Studies | 9 | 2019 | 5126 | 0.230 |
Why?
| | Prostheses and Implants | 1 | 2005 | 141 | 0.220 |
Why?
| | Triage | 2 | 2014 | 217 | 0.220 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.220 |
Why?
| | Age Factors | 9 | 2016 | 3290 | 0.210 |
Why?
| | Inflammation Mediators | 3 | 2004 | 514 | 0.210 |
Why?
| | Drainage | 3 | 2019 | 164 | 0.210 |
Why?
| | CD18 Antigens | 5 | 2002 | 26 | 0.200 |
Why?
| | Splenectomy | 3 | 2015 | 62 | 0.200 |
Why?
| | Macrophage-1 Antigen | 4 | 2002 | 29 | 0.200 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 21 | 0.190 |
Why?
| | Incidence | 9 | 2018 | 2783 | 0.190 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2000 | 316 | 0.180 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2015 | 201 | 0.180 |
Why?
| | Cardiopulmonary Bypass | 3 | 2003 | 209 | 0.180 |
Why?
| | Pulmonary Blastoma | 1 | 2021 | 8 | 0.180 |
Why?
| | Ribonuclease III | 1 | 2021 | 40 | 0.170 |
Why?
| | Thoracic Injuries | 2 | 2005 | 55 | 0.170 |
Why?
| | Ultrasonography, Interventional | 1 | 2021 | 142 | 0.170 |
Why?
| | DEAD-box RNA Helicases | 1 | 2021 | 76 | 0.170 |
Why?
| | Accidents, Traffic | 3 | 2011 | 189 | 0.170 |
Why?
| | Joint Dislocations | 1 | 2000 | 52 | 0.170 |
Why?
| | Empyema, Pleural | 1 | 2019 | 12 | 0.160 |
Why?
| | Proctocolectomy, Restorative | 1 | 2019 | 20 | 0.160 |
Why?
| | Adult | 25 | 2022 | 37595 | 0.160 |
Why?
| | Neuroblastoma | 2 | 2014 | 161 | 0.160 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2490 | 0.160 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 135 | 0.160 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2010 | 94 | 0.160 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 533 | 0.160 |
Why?
| | Fibrinolytic Agents | 2 | 2019 | 271 | 0.150 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 101 | 0.150 |
Why?
| | Cause of Death | 2 | 2014 | 431 | 0.150 |
Why?
| | Accidents, Home | 1 | 1998 | 30 | 0.150 |
Why?
| | Endothelial Cells | 2 | 2015 | 779 | 0.150 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.150 |
Why?
| | Diagnosis, Differential | 4 | 2014 | 1484 | 0.150 |
Why?
| | Thoracotomy | 3 | 2019 | 75 | 0.140 |
Why?
| | Pulmonary Artery | 2 | 2015 | 1084 | 0.140 |
Why?
| | Saline Solution, Hypertonic | 1 | 1998 | 41 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 531 | 0.140 |
Why?
| | Hernia, Inguinal | 1 | 1998 | 35 | 0.140 |
Why?
| | Molsidomine | 1 | 1997 | 5 | 0.140 |
Why?
| | Time Factors | 11 | 2014 | 6802 | 0.140 |
Why?
| | Age Distribution | 5 | 2003 | 391 | 0.140 |
Why?
| | Cyclic GMP | 1 | 1997 | 94 | 0.140 |
Why?
| | Prognosis | 7 | 2015 | 4011 | 0.140 |
Why?
| | Interleukin-8 | 2 | 2003 | 269 | 0.130 |
Why?
| | Patient Readmission | 3 | 2024 | 693 | 0.130 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 65 | 0.130 |
Why?
| | Kidney Neoplasms | 1 | 2021 | 398 | 0.130 |
Why?
| | Sex Distribution | 4 | 2002 | 378 | 0.130 |
Why?
| | Kidney | 2 | 2004 | 1460 | 0.120 |
Why?
| | Young Adult | 6 | 2022 | 13157 | 0.120 |
Why?
| | Anesthetics | 1 | 2016 | 81 | 0.120 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 5 | 0.120 |
Why?
| | Rectum | 2 | 2010 | 185 | 0.120 |
Why?
| | Injections, Intravenous | 1 | 2016 | 208 | 0.120 |
Why?
| | Trauma Severity Indices | 5 | 2013 | 106 | 0.120 |
Why?
| | Shock | 1 | 2016 | 93 | 0.120 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 15 | 0.120 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1240 | 0.120 |
Why?
| | Blood Substitutes | 2 | 2009 | 27 | 0.120 |
Why?
| | Recovery of Function | 2 | 2015 | 657 | 0.120 |
Why?
| | Preoperative Care | 2 | 2015 | 356 | 0.120 |
Why?
| | Analysis of Variance | 5 | 2004 | 1324 | 0.120 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.120 |
Why?
| | Interleukin-6 | 3 | 2004 | 771 | 0.120 |
Why?
| | Pneumothorax | 3 | 2021 | 38 | 0.120 |
Why?
| | Radiography, Thoracic | 2 | 2014 | 168 | 0.120 |
Why?
| | Isotonic Solutions | 1 | 2014 | 38 | 0.110 |
Why?
| | Shock, Traumatic | 1 | 2014 | 14 | 0.110 |
Why?
| | Nitric Oxide | 2 | 2013 | 914 | 0.110 |
Why?
| | Neurilemmoma | 1 | 2014 | 24 | 0.110 |
Why?
| | Sentinel Lymph Node Biopsy | 2 | 2005 | 114 | 0.110 |
Why?
| | Heart Rate | 2 | 2015 | 830 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Resuscitation | 3 | 2003 | 249 | 0.110 |
Why?
| | Specialties, Surgical | 2 | 2014 | 74 | 0.110 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 94 | 0.110 |
Why?
| | Hypertension, Pulmonary | 2 | 2016 | 1901 | 0.110 |
Why?
| | Clinical Protocols | 1 | 2015 | 268 | 0.110 |
Why?
| | Administration, Oral | 1 | 2016 | 811 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 84 | 0.100 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2014 | 89 | 0.100 |
Why?
| | Foreign Bodies | 1 | 2014 | 104 | 0.100 |
Why?
| | Referral and Consultation | 2 | 2018 | 779 | 0.100 |
Why?
| | Bronchiectasis | 1 | 2014 | 111 | 0.100 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2013 | 65 | 0.100 |
Why?
| | Lymphoma | 1 | 2014 | 207 | 0.100 |
Why?
| | Bronchi | 1 | 2014 | 259 | 0.100 |
Why?
| | Risk Assessment | 4 | 2015 | 3432 | 0.100 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 260 | 0.100 |
Why?
| | Acidosis | 1 | 2013 | 101 | 0.100 |
Why?
| | Blood Pressure | 3 | 2015 | 1774 | 0.100 |
Why?
| | Prospective Studies | 7 | 2006 | 7543 | 0.100 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 658 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2015 | 2471 | 0.090 |
Why?
| | Survival Rate | 5 | 2014 | 1972 | 0.090 |
Why?
| | Hematologic Diseases | 1 | 2011 | 62 | 0.090 |
Why?
| | Prader-Willi Syndrome | 1 | 2010 | 27 | 0.090 |
Why?
| | Thyroidectomy | 1 | 2011 | 107 | 0.090 |
Why?
| | Mortality | 1 | 2013 | 357 | 0.090 |
Why?
| | Rectal Prolapse | 1 | 2010 | 23 | 0.090 |
Why?
| | Purpura, Thrombocytopenic | 1 | 2010 | 4 | 0.080 |
Why?
| | Liver Cirrhosis, Biliary | 1 | 2010 | 18 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 79 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 160 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2010 | 30 | 0.080 |
Why?
| | Platelet Count | 1 | 2010 | 85 | 0.080 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2013 | 359 | 0.080 |
Why?
| | Intestinal Diseases | 1 | 2010 | 41 | 0.080 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 241 | 0.080 |
Why?
| | Coronary Artery Bypass | 2 | 2003 | 237 | 0.080 |
Why?
| | Lipopolysaccharides | 3 | 2009 | 882 | 0.080 |
Why?
| | Hernia, Diaphragmatic | 2 | 2013 | 65 | 0.080 |
Why?
| | Patient Discharge | 1 | 2016 | 887 | 0.080 |
Why?
| | Perioperative Care | 1 | 2011 | 182 | 0.080 |
Why?
| | General Surgery | 1 | 2011 | 170 | 0.080 |
Why?
| | Heme Oxygenase-1 | 1 | 2009 | 64 | 0.080 |
Why?
| | Parenteral Nutrition | 1 | 2010 | 107 | 0.080 |
Why?
| | Hirschsprung Disease | 1 | 2010 | 87 | 0.080 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2010 | 138 | 0.070 |
Why?
| | Melanoma | 2 | 2005 | 757 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 301 | 0.070 |
Why?
| | Interleukin-10 | 3 | 2004 | 302 | 0.070 |
Why?
| | Cellulitis | 1 | 2007 | 54 | 0.070 |
Why?
| | NADPH Oxidases | 2 | 1999 | 110 | 0.070 |
Why?
| | Skin Neoplasms | 2 | 2005 | 849 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 2013 | 545 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 284 | 0.070 |
Why?
| | Liver Neoplasms | 1 | 2013 | 783 | 0.070 |
Why?
| | Ultrasonography | 2 | 2003 | 749 | 0.070 |
Why?
| | Pediatrics | 2 | 2014 | 1119 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2000 | 816 | 0.060 |
Why?
| | Pancreatic Neoplasms | 1 | 2014 | 941 | 0.060 |
Why?
| | United States | 6 | 2014 | 14595 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2004 | 1242 | 0.060 |
Why?
| | Mammary Arteries | 1 | 2005 | 7 | 0.060 |
Why?
| | Viscera | 1 | 2005 | 17 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 35 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 624 | 0.060 |
Why?
| | Pylorus | 1 | 2005 | 17 | 0.060 |
Why?
| | Foreign-Body Migration | 1 | 2005 | 34 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 9 | 0.060 |
Why?
| | Abdominal Pain | 1 | 2006 | 146 | 0.060 |
Why?
| | Patient Selection | 2 | 2010 | 690 | 0.060 |
Why?
| | Nevus, Pigmented | 1 | 2005 | 32 | 0.060 |
Why?
| | Renal Veins | 1 | 2004 | 19 | 0.060 |
Why?
| | Renal Artery | 1 | 2004 | 37 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2015 | 619 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2016 | 1945 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2010 | 832 | 0.050 |
Why?
| | Phospholipases A2 | 2 | 2001 | 80 | 0.050 |
Why?
| | Diaphragm | 1 | 2004 | 42 | 0.050 |
Why?
| | Interleukin-11 | 2 | 2003 | 10 | 0.050 |
Why?
| | Hernia, Umbilical | 1 | 2003 | 16 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 5 | 0.050 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 225 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2013 | 2030 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 54 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 168 | 0.050 |
Why?
| | Appendix | 1 | 2003 | 30 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 32 | 0.050 |
Why?
| | Stroke | 1 | 2011 | 1122 | 0.050 |
Why?
| | Cytokines | 2 | 2009 | 2078 | 0.050 |
Why?
| | Middle Aged | 10 | 2014 | 33118 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 158 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1999 | 151 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 97 | 0.050 |
Why?
| | Recurrence | 1 | 2005 | 1058 | 0.050 |
Why?
| | Infant, Premature, Diseases | 1 | 2003 | 101 | 0.050 |
Why?
| | Pulmonary Edema | 1 | 2002 | 106 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2003 | 170 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 175 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2002 | 191 | 0.050 |
Why?
| | Peritonitis | 1 | 2002 | 83 | 0.050 |
Why?
| | Catheterization, Central Venous | 1 | 2003 | 111 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2003 | 263 | 0.050 |
Why?
| | Sheep | 2 | 2015 | 854 | 0.050 |
Why?
| | Bites and Stings | 1 | 2001 | 32 | 0.050 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 187 | 0.040 |
Why?
| | Critical Care | 2 | 2003 | 583 | 0.040 |
Why?
| | Pyridoxal Phosphate | 1 | 2001 | 24 | 0.040 |
Why?
| | Kidney Diseases, Cystic | 1 | 2021 | 24 | 0.040 |
Why?
| | Esophageal Achalasia | 1 | 2001 | 30 | 0.040 |
Why?
| | Decision Support Techniques | 2 | 2015 | 413 | 0.040 |
Why?
| | Wounds, Penetrating | 1 | 2001 | 65 | 0.040 |
Why?
| | CD11 Antigens | 2 | 1998 | 30 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 963 | 0.040 |
Why?
| | Syndrome | 1 | 2021 | 359 | 0.040 |
Why?
| | CHO Cells | 2 | 1998 | 161 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 171 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2002 | 1108 | 0.040 |
Why?
| | Cricetinae | 2 | 1998 | 288 | 0.040 |
Why?
| | Hospital Mortality | 2 | 2014 | 901 | 0.040 |
Why?
| | Esophagoscopy | 1 | 2001 | 206 | 0.040 |
Why?
| | Inflammation | 4 | 2001 | 2817 | 0.040 |
Why?
| | Sialoglycoproteins | 1 | 1999 | 159 | 0.040 |
Why?
| | NF-kappa B | 1 | 2003 | 685 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1999 | 164 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 321 | 0.040 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2002 | 244 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1063 | 0.040 |
Why?
| | Logistic Models | 2 | 2015 | 2060 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 1999 | 216 | 0.040 |
Why?
| | Antibodies, Monoclonal | 3 | 2010 | 1417 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 1999 | 253 | 0.040 |
Why?
| | Phosphatidic Acids | 1 | 1998 | 9 | 0.040 |
Why?
| | Vas Deferens | 1 | 1998 | 19 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1524 | 0.040 |
Why?
| | Receptors, Peptide | 1 | 1998 | 17 | 0.040 |
Why?
| | Signal Transduction | 3 | 2015 | 5077 | 0.040 |
Why?
| | Blood Bactericidal Activity | 1 | 1998 | 36 | 0.040 |
Why?
| | Alprostadil | 1 | 1998 | 32 | 0.040 |
Why?
| | Endopeptidases | 1 | 1998 | 90 | 0.040 |
Why?
| | Animals | 8 | 2015 | 36915 | 0.040 |
Why?
| | Heart Arrest | 1 | 2002 | 335 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 1998 | 174 | 0.040 |
Why?
| | Hospitalization | 3 | 2014 | 2183 | 0.040 |
Why?
| | Cell Physiological Phenomena | 1 | 1997 | 19 | 0.040 |
Why?
| | Myocardium | 1 | 2003 | 1004 | 0.040 |
Why?
| | Dibutyryl Cyclic GMP | 1 | 1997 | 2 | 0.040 |
Why?
| | Pneumonia | 1 | 2003 | 631 | 0.040 |
Why?
| | Respiratory Burst | 1 | 1997 | 16 | 0.040 |
Why?
| | Calcium | 2 | 2001 | 1233 | 0.030 |
Why?
| | Transfection | 2 | 1998 | 948 | 0.030 |
Why?
| | Femoral Fractures | 1 | 1998 | 78 | 0.030 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 1997 | 22 | 0.030 |
Why?
| | Aged | 5 | 2014 | 23641 | 0.030 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 1998 | 66 | 0.030 |
Why?
| | Isoproterenol | 1 | 1997 | 116 | 0.030 |
Why?
| | Cells, Cultured | 4 | 2013 | 4204 | 0.030 |
Why?
| | Contrast Media | 2 | 2015 | 462 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Insufflation | 1 | 1996 | 12 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 1998 | 223 | 0.030 |
Why?
| | North Carolina | 1 | 2016 | 105 | 0.030 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1997 | 127 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1997 | 133 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1997 | 385 | 0.030 |
Why?
| | Bone Marrow | 1 | 1998 | 286 | 0.030 |
Why?
| | Cell Death | 1 | 1998 | 370 | 0.030 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 922 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1996 | 211 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 834 | 0.030 |
Why?
| | Solubility | 1 | 1996 | 248 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 610 | 0.030 |
Why?
| | Osteosarcoma | 1 | 1996 | 75 | 0.030 |
Why?
| | Awards and Prizes | 1 | 1996 | 68 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 344 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 131 | 0.030 |
Why?
| | Hypoxia | 1 | 2002 | 1106 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 1996 | 267 | 0.030 |
Why?
| | Needs Assessment | 1 | 2016 | 368 | 0.030 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 259 | 0.030 |
Why?
| | Models, Biological | 2 | 2002 | 1774 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 690 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 240 | 0.030 |
Why?
| | Craniotomy | 1 | 2014 | 78 | 0.030 |
Why?
| | Kinetics | 1 | 1997 | 1679 | 0.030 |
Why?
| | Lymphatic Metastasis | 2 | 2005 | 349 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4281 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2013 | 66 | 0.030 |
Why?
| | Motor Skills | 1 | 2014 | 99 | 0.030 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 58 | 0.030 |
Why?
| | Fluid Therapy | 1 | 2014 | 147 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 132 | 0.030 |
Why?
| | Endothelin-1 | 1 | 2015 | 181 | 0.030 |
Why?
| | Ethanol | 1 | 1998 | 608 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 163 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 346 | 0.020 |
Why?
| | Flow Cytometry | 1 | 1996 | 1185 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 620 | 0.020 |
Why?
| | Infant, Premature | 1 | 2016 | 563 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2013 | 176 | 0.020 |
Why?
| | Reoperation | 2 | 2006 | 568 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2416 | 0.020 |
Why?
| | Up-Regulation | 3 | 2001 | 846 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 26 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 41 | 0.020 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 216 | 0.020 |
Why?
| | Neoplasm Staging | 2 | 2006 | 1376 | 0.020 |
Why?
| | Health Care Costs | 1 | 2014 | 386 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 366 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 36 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 512 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 44 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 181 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 543 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 56 | 0.020 |
Why?
| | Rho(D) Immune Globulin | 1 | 2010 | 3 | 0.020 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 2 | 2002 | 56 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 434 | 0.020 |
Why?
| | Heparin | 1 | 2011 | 259 | 0.020 |
Why?
| | Parenteral Nutrition, Total | 1 | 2010 | 26 | 0.020 |
Why?
| | Antigens, CD20 | 1 | 2010 | 28 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2014 | 643 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 192 | 0.020 |
Why?
| | Lung Diseases | 1 | 2016 | 768 | 0.020 |
Why?
| | Cell Line | 2 | 2009 | 2847 | 0.020 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 88 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1320 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 72 | 0.020 |
Why?
| | Protoporphyrins | 1 | 2009 | 16 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 90 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2011 | 565 | 0.020 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2010 | 132 | 0.020 |
Why?
| | Steroids | 1 | 2010 | 166 | 0.020 |
Why?
| | Rituximab | 1 | 2010 | 172 | 0.020 |
Why?
| | Treatment Failure | 1 | 2010 | 353 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 123 | 0.020 |
Why?
| | Transcription Factor RelA | 1 | 2009 | 86 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 289 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1026 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 547 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 181 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 799 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 445 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2011 | 454 | 0.020 |
Why?
| | Intestinal Perforation | 1 | 2007 | 46 | 0.020 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 211 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 249 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3282 | 0.020 |
Why?
| | Pancreas | 1 | 2010 | 328 | 0.020 |
Why?
| | Comorbidity | 2 | 2003 | 1611 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 338 | 0.020 |
Why?
| | Anticoagulants | 1 | 2011 | 662 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 32 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 615 | 0.020 |
Why?
| | Equipment Failure | 1 | 2006 | 107 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 845 | 0.010 |
Why?
| | Databases, Factual | 1 | 2011 | 1345 | 0.010 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 116 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 5711 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 105 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 93 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 11 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 10 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 42 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 55 | 0.010 |
Why?
| | E-Selectin | 1 | 2003 | 58 | 0.010 |
Why?
| | Infant, Low Birth Weight | 1 | 2003 | 139 | 0.010 |
Why?
| | Monokines | 1 | 2002 | 22 | 0.010 |
Why?
| | Chemokine CXCL2 | 1 | 2002 | 43 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 65 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2744 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 500 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 157 | 0.010 |
Why?
| | Safety | 1 | 2004 | 341 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 110 | 0.010 |
Why?
| | Probability | 1 | 2002 | 311 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2003 | 183 | 0.010 |
Why?
| | Egtazic Acid | 1 | 2001 | 41 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2002 | 331 | 0.010 |
Why?
| | Umbilical Veins | 1 | 2001 | 61 | 0.010 |
Why?
| | Barium Sulfate | 1 | 2001 | 15 | 0.010 |
Why?
| | Spine | 1 | 2003 | 174 | 0.010 |
Why?
| | Chelating Agents | 1 | 2001 | 75 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 186 | 0.010 |
Why?
| | Manometry | 1 | 2001 | 95 | 0.010 |
Why?
| | Cytosol | 1 | 2001 | 227 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 434 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2001 | 117 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 411 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 844 | 0.010 |
Why?
| | Acute Disease | 1 | 2002 | 1000 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 153 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2709 | 0.010 |
Why?
| | Receptors, Formyl Peptide | 1 | 1998 | 7 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 283 | 0.010 |
Why?
| | Spinal Cord Injuries | 1 | 2002 | 209 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1998 | 434 | 0.010 |
Why?
| | Protease Inhibitors | 1 | 1998 | 107 | 0.010 |
Why?
| | Colforsin | 1 | 1997 | 54 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 212 | 0.010 |
Why?
| | Alcoholic Intoxication | 1 | 1998 | 66 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2067 | 0.010 |
Why?
| | Body Weight | 1 | 2001 | 973 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 466 | 0.010 |
Why?
| | Critical Illness | 1 | 2001 | 805 | 0.010 |
Why?
| | Reperfusion Injury | 1 | 1997 | 278 | 0.010 |
Why?
| | Trachea | 1 | 1996 | 235 | 0.010 |
Why?
| | Down-Regulation | 1 | 1997 | 658 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2615 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 1997 | 545 | 0.010 |
Why?
| | Rats | 1 | 2002 | 5675 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2005 | 7552 | 0.010 |
Why?
| | Apoptosis | 1 | 2002 | 2542 | 0.010 |
Why?
| | Mice | 1 | 2009 | 17775 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 4148 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2002 | 2033 | 0.010 |
Why?
| | Macrophages | 1 | 1997 | 1547 | 0.010 |
Why?
|
|
Partrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|